Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1972 5
1973 9
1974 9
1975 9
1976 5
1977 7
1978 9
1979 8
1980 6
1981 7
1982 5
1983 3
1984 6
1985 2
1986 2
1987 2
1988 2
1989 4
1990 2
1991 4
1992 8
1993 4
1994 1
1995 4
1996 6
1997 4
1998 4
1999 4
2000 3
2001 5
2002 6
2003 10
2004 10
2005 10
2006 10
2007 13
2008 16
2009 10
2010 8
2011 7
2012 15
2013 13
2014 10
2015 7
2016 11
2017 14
2018 11
2019 5
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

313 results
Results by year
Filters applied: . Clear all
Page 1
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
Rabinovici GD, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, Hendrix J, Hillner BE, Olson C, Lesman-Segev OH, Romanoff J, Siegel BA, Whitmer RA, Carrillo MC. Rabinovici GD, et al. Among authors: siegel ba. JAMA. 2019 Apr 2;321(13):1286-1294. doi: 10.1001/jama.2019.2000. JAMA. 2019. PMID: 30938796 Free PMC article.
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial.
Bartlett NL, Costello BA, LaPlant BR, Ansell SM, Kuruvilla JG, Reeder CB, Thye LS, Anderson DM, Krysiak K, Ramirez C, Qi J, Siegel BA, Griffith M, Griffith OL, Gomez F, Fehniger TA. Bartlett NL, et al. Among authors: siegel ba. Blood. 2018 Jan 11;131(2):182-190. doi: 10.1182/blood-2017-09-804641. Epub 2017 Oct 26. Blood. 2018. PMID: 29074501 Free PMC article. Clinical Trial.
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.
Andriole GL, Kostakoglu L, Chau A, Duan F, Mahmood U, Mankoff DA, Schuster DM, Siegel BA; LOCATE Study Group. Andriole GL, et al. Among authors: siegel ba. J Urol. 2019 Feb;201(2):322-331. doi: 10.1016/j.juro.2018.08.050. J Urol. 2019. PMID: 30179618 Free PMC article. Clinical Trial.
Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
Lin AJ, Kidd E, Dehdashti F, Siegel BA, Mutic S, Thaker PH, Massad LS, Powell MA, Mutch DG, Markovina S, Schwarz J, Grigsby PW. Lin AJ, et al. Among authors: siegel ba. Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1088-1097. doi: 10.1016/j.ijrobp.2018.11.012. Epub 2018 Nov 14. Int J Radiat Oncol Biol Phys. 2019. PMID: 30445171 Free PMC article.
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.
Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA. Dehdashti F, et al. Among authors: siegel ba. Breast Cancer Res Treat. 2018 Jun;169(3):523-530. doi: 10.1007/s10549-018-4696-z. Epub 2018 Feb 13. Breast Cancer Res Treat. 2018. PMID: 29442264 Free PMC article.
Adrenal Histoplasmosis.
Sanders V, Donald J, Siegel BA. Sanders V, et al. Among authors: siegel ba. Clin Nucl Med. 2018 Jul;43(7):502-503. doi: 10.1097/RLU.0000000000002094. Clin Nucl Med. 2018. PMID: 29762233
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study.
Munster P, Krop IE, LoRusso P, Ma C, Siegel BA, Shields AF, Moln√°r I, Wickham TJ, Reynolds J, Campbell K, Hendriks BS, Adiwijaya BS, Geretti E, Moyo V, Miller KD. Munster P, et al. Among authors: siegel ba. Br J Cancer. 2018 Oct;119(9):1086-1093. doi: 10.1038/s41416-018-0235-2. Epub 2018 Oct 26. Br J Cancer. 2018. PMID: 30361524 Free PMC article. Clinical Trial.
Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
Markovina S, Wang S, Henke LE, Luke CJ, Pak SC, DeWees T, Pfeifer JD, Schwarz JK, Liu W, Chen S, Mutch D, Wang X, Powell MA, Siegel BA, Dehdashti F, Silverman GA, Grigsby PW. Markovina S, et al. Among authors: siegel ba. Br J Cancer. 2018 Jan;118(1):72-78. doi: 10.1038/bjc.2017.390. Epub 2017 Nov 7. Br J Cancer. 2018. PMID: 29112685 Free PMC article.
64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.
Lee H, Shields AF, Siegel BA, Miller KD, Krop I, Ma CX, LoRusso PM, Munster PN, Campbell K, Gaddy DF, Leonard SC, Geretti E, Blocker SJ, Kirpotin DB, Moyo V, Wickham TJ, Hendriks BS. Lee H, et al. Among authors: siegel ba. Clin Cancer Res. 2017 Aug 1;23(15):4190-4202. doi: 10.1158/1078-0432.CCR-16-3193. Epub 2017 Mar 15. Clin Cancer Res. 2017. PMID: 28298546 Free PMC article. Clinical Trial.
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
Salavati A, Duan F, Snyder BS, Wei B, Houshmand S, Khiewvan B, Opanowski A, Simone CB 2nd, Siegel BA, Machtay M, Alavi A. Salavati A, et al. Among authors: siegel ba. Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1969-1983. doi: 10.1007/s00259-017-3753-x. Epub 2017 Jul 8. Eur J Nucl Med Mol Imaging. 2017. PMID: 28689281 Free PMC article. Clinical Trial.
313 results
Jump to page